Enfusion

Enfusion FCF Conversion

Delisted

The FCF Conversion Rate (FCF/EBITDA) of Enfusion (ENFN) as of Nov 7, 2026 is 1,099.79 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 264.95 % — a change of 315.10% (higher).

FCF Conversion

1,099.79 %

YoY

315.10%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Enfusion is 2024 1,099.79 % . FCF Conversion Rate (FCF/EBITDA) of Enfusion was 2023 264.95 % . It decreases by 315.10% higher compared to the previous year.

The Enfusion FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2019
62.24 USD
Jan 1, 2020
-83.80 USD
Jan 1, 2021
2.95 USD
Jan 1, 2022
-46.94 USD
Jan 1, 2023
264.95 USD
Jan 1, 2024
1,099.79 USD
The Enfusion FCF Conversion history
YEARFCF ConversionYoY
1,099.79 %+315.10%
264.95 %-664.49%
-46.94 %-1,689.90%
2.95 %-103.52%
-83.80 %-234.64%
62.24 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enfusion Stock analysis

What does Enfusion do? Enfusion Inc. generates revenue through cloud-native multi-tenant software solutions tailored for alternative and institutional investment managers. Its core products include the Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System, and Enfusion Analytics System, which collectively enable real-time investment decision-making. The company serves investment managers who require integrated systems for the full investment lifecycle, with PMS constructing and rebalancing portfolios while generating a real-time investment book of record, and OEMS facilitating electronic trade order communication for portfolio managers, traders, compliance teams, and analysts. The company's solution integrates technology-powered managed services to drive insights and control over investment operations. Enfusion's end-to-end functionality supports the entire investment process, from portfolio construction to trade execution, with PMS and OEMS operating in tandem to provide a seamless workflow. Investment managers across alternative and institutional segments purchase these integrated systems to enhance operational efficiency and decision-making capabilities. Enfusion's software is designed to serve the full investment lifecycle, with its systems integrated to provide a unified platform for portfolio management, order execution, accounting, and analytics. The company's revenue model is based on delivering these comprehensive solutions to investment managers who rely on real-time data and integrated workflows to manage their operations effectively. Enfusion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enfusion stock

FCF Conversion Rate (FCF/EBITDA) of Enfusion is 1,099.79 % in 2024.

FCF Conversion Rate (FCF/EBITDA) of Enfusion changed from 264.95 % to 1,099.79 %, representing a 315.10% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Enfusion since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Enfusion with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Enfusion

All Key Metrics — Enfusion